Overview

Proteon 320 Study

Multicenter, Double-Blind, Placebo-Controlled Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease

Objective

This research study is enrolling patients with chronic kidney disease from Lake Washington Vascular who will undergo a Radiocephalic Arteriovenous Fistula creation to create a new access to their bloodstream for hemodialysis. This study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase.

 

Study Coordinator(s)

Krissa Gunderson, CRC

Phone: 425.732.5958

krissag@lkwv.com

 

Irina Stipek, CRC

Phone: 425.732.5959

irinas@lkwv.com

 

Clinical Trial Categories

Vascular / Surgical

View all hospital services

Make a gift

Need urgent care?